Skip to main content
Erschienen in: Diabetologia 7/2015

01.07.2015 | Article

The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics

verfasst von: Martha Lappas, Piyushkumar A. Mundra, Gerard Wong, Kevin Huynh, Debra Jinks, Harry M. Georgiou, Michael Permezel, Peter J. Meikle

Erschienen in: Diabetologia | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The risk of developing diabetes is greater for women with previous gestational diabetes mellitus (GDM). In the general population, plasma lipidomic analysis can identify individuals at risk of developing type 2 diabetes. The aim of this study was to determine whether circulating lipid levels 12 weeks following a GDM pregnancy were associated with an increased risk of developing type 2 diabetes.

Methods

Plasma lipid profiles containing >300 lipids were measured in 104 normal glucose-tolerant women 12 weeks following an index GDM pregnancy using electrospray-ionisation tandem mass spectrometry. Women were assessed for 10 years for development of overt type 2 diabetes.

Results

Among the 104 women with previous GDM, 21 (20%) developed diabetes during the median follow-up period of 8.5 years. Three lipid species, the cholesteryl ester species CE 20:4, the alkenylphosphatidylethanolamine species PE(P-36:2) and the phosphatidylserine species PS 38:4, were independently and positively associated with the development of type 2 diabetes. In a clinical model of prediction of type 2 diabetes that included age, BMI, and levels of pregnancy fasting glucose, postnatal fasting glucose, triacylglycerol and total cholesterol, the addition of these three lipid species resulted in an improvement in the net reclassification index of 22.3%.

Conclusions/interpretation

The lipid species CE 20:4, PE(P-36:2) and PS 38:4 were significant risk factors for the development of type 2 diabetes in women with a previous history of GDM. This report is the first to use plasma lipidomic analysis to identify individual lipids as potential biomarkers for the prediction of type 2 diabetes in women with a history of GDM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14PubMedCrossRef Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14PubMedCrossRef
2.
Zurück zum Zitat Roglic G, Unwin N, Bennett PH et al (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28:2130–2135PubMedCrossRef Roglic G, Unwin N, Bennett PH et al (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28:2130–2135PubMedCrossRef
3.
Zurück zum Zitat Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8:228–236CrossRef Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8:228–236CrossRef
4.
Zurück zum Zitat Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 356:213–215PubMedCrossRef Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 356:213–215PubMedCrossRef
5.
Zurück zum Zitat Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M (2007) Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30:878–883PubMedCrossRef Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M (2007) Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30:878–883PubMedCrossRef
6.
Zurück zum Zitat Akinci B, Celtik A, Yener S, Yesil S (2010) Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 93:1248–1254PubMedCrossRef Akinci B, Celtik A, Yener S, Yesil S (2010) Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 93:1248–1254PubMedCrossRef
7.
Zurück zum Zitat Bo S, Monge L, Macchetta C et al (2004) Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Investig 27:629–635CrossRef Bo S, Monge L, Macchetta C et al (2004) Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Investig 27:629–635CrossRef
8.
Zurück zum Zitat Lappas M, Jinks D, Ugoni A, Louizos CC, Permezel M, Georgiou HM (2014) Postpartum plasma C-peptide and ghrelin concentrations are predictive of type 2 diabetes in women with previous gestational diabetes mellitus. J Diabetes. doi:10.1111/1753-0407.12209 Lappas M, Jinks D, Ugoni A, Louizos CC, Permezel M, Georgiou HM (2014) Postpartum plasma C-peptide and ghrelin concentrations are predictive of type 2 diabetes in women with previous gestational diabetes mellitus. J Diabetes. doi:10.​1111/​1753-0407.​12209
9.
Zurück zum Zitat Bonora E, Targher G, Alberiche M et al (2002) Predictors of insulin sensitivity in type 2 diabetes mellitus. Diabet Med 19:535–542PubMedCrossRef Bonora E, Targher G, Alberiche M et al (2002) Predictors of insulin sensitivity in type 2 diabetes mellitus. Diabet Med 19:535–542PubMedCrossRef
10.
Zurück zum Zitat Joseph J, Svartberg J, Njolstad I, Schirmer H (2011) Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromso Study. Eur J Epidemiol 26:117–124PubMedCentralPubMedCrossRef Joseph J, Svartberg J, Njolstad I, Schirmer H (2011) Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromso Study. Eur J Epidemiol 26:117–124PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648PubMedCentralPubMedCrossRef Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Wong G, Barlow CK, Weir JM et al (2013) Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes. PLOS ONE 8:e76577 Wong G, Barlow CK, Weir JM et al (2013) Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes. PLOS ONE 8:e76577
13.
Zurück zum Zitat Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRef Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRef
15.
Zurück zum Zitat Anderson SG, Dunn WB, Banerjee M et al (2014) Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLOS ONE 9:e103217 Anderson SG, Dunn WB, Banerjee M et al (2014) Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLOS ONE 9:e103217
16.
Zurück zum Zitat Meikle PJ, Wong G, Barlow CK et al (2013) Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLOS ONE 8:e74341 Meikle PJ, Wong G, Barlow CK et al (2013) Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLOS ONE 8:e74341
17.
Zurück zum Zitat Meikle PJ, Wong G, Barlow CK, Kingwell BA (2014) Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacol Ther 143:12–23PubMedCrossRef Meikle PJ, Wong G, Barlow CK, Kingwell BA (2014) Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacol Ther 143:12–23PubMedCrossRef
18.
Zurück zum Zitat Rhee EP, Cheng S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402–1411PubMedCentralPubMedCrossRef Rhee EP, Cheng S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402–1411PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Boon J, Hoy AJ, Stark R et al (2013) Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 62:401–410PubMedCentralPubMedCrossRef Boon J, Hoy AJ, Stark R et al (2013) Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 62:401–410PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat de Mello VD, Lankinen M, Schwab U et al (2009) Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 52:2612–2615PubMedCrossRef de Mello VD, Lankinen M, Schwab U et al (2009) Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 52:2612–2615PubMedCrossRef
21.
Zurück zum Zitat Boslem E, MacIntosh G, Preston AM et al (2011) A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 435:267–276PubMedCrossRef Boslem E, MacIntosh G, Preston AM et al (2011) A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 435:267–276PubMedCrossRef
22.
Zurück zum Zitat Manukyan L, Ubhayasekera SJ, Bergquist J, Sargsyan E, Bergsten P (2015) Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine. Endocrinology 156:802–812PubMedCrossRef Manukyan L, Ubhayasekera SJ, Bergquist J, Sargsyan E, Bergsten P (2015) Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine. Endocrinology 156:802–812PubMedCrossRef
23.
24.
Zurück zum Zitat Lessig J, Fuchs B (2009) Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Curr Med Chem 16:2021–2041PubMedCrossRef Lessig J, Fuchs B (2009) Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Curr Med Chem 16:2021–2041PubMedCrossRef
25.
Zurück zum Zitat Maeba R, Ueta N (2003) Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers. J Lipid Res 44:164–171PubMedCrossRef Maeba R, Ueta N (2003) Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers. J Lipid Res 44:164–171PubMedCrossRef
26.
Zurück zum Zitat Mankidy R, Ahiahonu PW, Ma H et al (2010) Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study. Lipids Health Dis 9:62PubMedCentralPubMedCrossRef Mankidy R, Ahiahonu PW, Ma H et al (2010) Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study. Lipids Health Dis 9:62PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Meikle PJ, Wong G, Tsorotes D et al (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31:2723–2732PubMedCrossRef Meikle PJ, Wong G, Tsorotes D et al (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31:2723–2732PubMedCrossRef
28.
Zurück zum Zitat Barden A, Singh R, Walters B, Phillips M, Beilin LJ (2013) A simple scoring method using cardiometabolic risk measurements in pregnancy to determine 10-year risk of type 2 diabetes in women with gestational diabetes. Nutr Diabetes 3, e72PubMedCentralPubMedCrossRef Barden A, Singh R, Walters B, Phillips M, Beilin LJ (2013) A simple scoring method using cardiometabolic risk measurements in pregnancy to determine 10-year risk of type 2 diabetes in women with gestational diabetes. Nutr Diabetes 3, e72PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93:4774–4779PubMedCentralPubMedCrossRef Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93:4774–4779PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796–2803PubMedCrossRef Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796–2803PubMedCrossRef
Metadaten
Titel
The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics
verfasst von
Martha Lappas
Piyushkumar A. Mundra
Gerard Wong
Kevin Huynh
Debra Jinks
Harry M. Georgiou
Michael Permezel
Peter J. Meikle
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 7/2015
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3587-7

Weitere Artikel der Ausgabe 7/2015

Diabetologia 7/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.